Related references
Note: Only part of the references are listed.Triazole Ureas Act as Diacylglycerol Lipase Inhibitors and Prevent Fasting-Induced Refeeding
Hui Deng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Short-term Cold Acclimation Recruits Brown Adipose Tissue in Obese Humans
Mark J. W. Hanssen et al.
DIABETES (2016)
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders
Freek J. Janssen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Endocannabinoid regulation in white and brown adipose tissue following thermogenic activation
Lucia M. Krott et al.
JOURNAL OF LIPID RESEARCH (2016)
Circadian Rhythm of Circulating Levels of the Endocannabinoid 2-Arachidonoylglycerol
E. C. Hanlon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
A peripheral endocannabinoid mechanism contributes to glucocorticoid-mediated metabolic syndrome
Nicole P. Bowles et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Integrating Metabolomics Profiling Measurements Across Multiple Biobanks
A. D. Dane et al.
ANALYTICAL CHEMISTRY (2014)
Peripheral cannabinoid 1 receptor blockade activates brown adipose tissue and diminishes dyslipidemia and obesity
Mariette R. Boon et al.
FASEB JOURNAL (2014)
Brown adipose tissue volume in healthy lean south Asian adults compared with white Caucasians: a prospective, case-controlled observational study
Leontine E. H. Bakker et al.
LANCET DIABETES & ENDOCRINOLOGY (2014)
Cold acclimation recruits human brown fat and increases nonshivering thermogenesis
Anouk A. J. J. van der Lans et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes
Tony Jourdan et al.
NATURE MEDICINE (2013)
Acute Stress Increases Circulating Anandamide and Other N-Acylethanolamines in Healthy Humans
Andrea Dlugos et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Deriving Ethnic-Specific BMI Cutoff Points for Assessing Diabetes Risk
Maria Chiu et al.
DIABETES CARE (2011)
Central and Peripheral Endocannabinoids and Cognate Acylethanolamides in Humans: Association with Race, Adiposity, and Energy Expenditure
Reiner Jumpertz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Adipocyte Hypertrophy, Fatty Liver and Metabolic Risk Factors in South Asians: The Molecular Study of Health and Risk in Ethnic Groups (mol-SHARE)
Sonia S. Anand et al.
PLOS ONE (2011)
Peripheral effects of the endocannabinoid system in energy homeostasis: Adipose tissue, liver and skeletal muscle
Cristoforo Silvestri et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2011)
Fat Oxidation, Fitness and Skeletal Muscle Expression of Oxidative/Lipid Metabolism Genes in South Asians: Implications for Insulin Resistance?
Lesley M. L. Hall et al.
PLOS ONE (2010)
Effect of Rimonabant on the High-Triglyceride/Low-HDL-Cholesterol Dyslipidemia, Intraabdominal Adiposity, and Liver Fat The ADAGIO-Lipids Trial
Jean-Pierre Despres et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Brief Report: Functional Brown Adipose Tissue in Healthy Adults.
Kirsi A. Virtanen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cold-Activated Brown Adipose Tissue in Healthy Men
Wouter D. van Marken Lichtenbelt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Identification and Importance of Brown Adipose Tissue in Adult Humans.
Aaron M. Cypess et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver
Won-il Jeong et al.
CELL METABOLISM (2008)
The acyclic CB1R inverse agonist taranabant mediates weight loss by increasing energy expenditure and decreasing caloric intake
Carol Addy et al.
CELL METABOLISM (2008)
Hepatic CB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice
Douglas Osei-Hyiaman et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Dysregulation of the endocannabinoid system in obesity
S. Engeli
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Role and regulation of acylethanolamides in energy balance:: focus on adipocytes and β-cells
I. Matias et al.
BRITISH JOURNAL OF PHARMACOLOGY (2007)
Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats
Magali Gary-Bobo et al.
HEPATOLOGY (2007)
Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men
M. Cote et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity
Matthias Blueher et al.
DIABETES (2006)
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
JP Despres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Activation of the peripheral endocannabinoid system in human obesity
S Engeli et al.
DIABETES (2005)
Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients:: 1-year experience from the RIO-Europe study
LF Van Gaal et al.
LANCET (2005)
Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α
J Fu et al.
NATURE (2003)
Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice
CR Trillou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2003)
An anorexic lipid mediator regulated by feeding
FR de Fonseca et al.
NATURE (2001)
Share Paper
